BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35149361)

  • 21. Quality control of the proteins associated with neurodegenerative diseases.
    Gao X; Hu H
    Acta Biochim Biophys Sin (Shanghai); 2008 Jul; 40(7):612-8. PubMed ID: 18604452
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhanced Clearance of Neurotoxic Misfolded Proteins by the Natural Compound Berberine and Its Derivatives.
    Rusmini P; Cristofani R; Tedesco B; Ferrari V; Messi E; Piccolella M; Casarotto E; Chierichetti M; Cicardi ME; Galbiati M; Geroni C; Lombardi P; Crippa V; Poletti A
    Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32414108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common Factors in Neurodegeneration: A Meta-Study Revealing Shared Patterns on a Multi-Omics Scale.
    Ruffini N; Klingenberg S; Schweiger S; Gerber S
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protein Quality Control by Molecular Chaperones in Neurodegeneration.
    Ciechanover A; Kwon YT
    Front Neurosci; 2017; 11():185. PubMed ID: 28428740
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
    Sinnige T; Yu A; Morimoto RI
    Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of neurodegeneration by molecular chaperones.
    Muchowski PJ; Wacker JL
    Nat Rev Neurosci; 2005 Jan; 6(1):11-22. PubMed ID: 15611723
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aggregopathy in neurodegenerative diseases: mechanisms and therapeutic implication.
    Dohm CP; Kermer P; Bähr M
    Neurodegener Dis; 2008; 5(6):321-38. PubMed ID: 18309232
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Ubiquitin-Proteasome System and Molecular Chaperone Deregulation in Alzheimer's Disease.
    Sulistio YA; Heese K
    Mol Neurobiol; 2016 Mar; 53(2):905-931. PubMed ID: 25561438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct proteostasis circuits cooperate in nuclear and cytoplasmic protein quality control.
    Samant RS; Livingston CM; Sontag EM; Frydman J
    Nature; 2018 Nov; 563(7731):407-411. PubMed ID: 30429547
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeting chaperones, heat shock factor-1, and unfolded protein response: Promising therapeutic approaches for neurodegenerative disorders.
    Bose S; Cho J
    Ageing Res Rev; 2017 May; 35():155-175. PubMed ID: 27702699
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mitochondrial diseases of the brain.
    Chaturvedi RK; Flint Beal M
    Free Radic Biol Med; 2013 Oct; 63():1-29. PubMed ID: 23567191
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cellular maintenance of nuclear protein homeostasis.
    Gallagher PS; Oeser ML; Abraham AC; Kaganovich D; Gardner RG
    Cell Mol Life Sci; 2014 May; 71(10):1865-79. PubMed ID: 24305949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protein Misfolding Diseases.
    Hartl FU
    Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mitophagy in neurodegenerative diseases.
    Rodolfo C; Campello S; Cecconi F
    Neurochem Int; 2018 Jul; 117():156-166. PubMed ID: 28797885
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clearance of misfolded and aggregated proteins by aggrephagy and implications for aggregation diseases.
    Hyttinen JM; Amadio M; Viiri J; Pascale A; Salminen A; Kaarniranta K
    Ageing Res Rev; 2014 Nov; 18():16-28. PubMed ID: 25062811
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transgenic animal models of neurodegeneration based on human genetic studies.
    Harvey BK; Richie CT; Hoffer BJ; Airavaara M
    J Neural Transm (Vienna); 2011 Jan; 118(1):27-45. PubMed ID: 20931247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Amyotrophic lateral sclerosis is a non-amyloid disease in which extensive misfolding of SOD1 is unique to the familial form.
    Kerman A; Liu HN; Croul S; Bilbao J; Rogaeva E; Zinman L; Robertson J; Chakrabartty A
    Acta Neuropathol; 2010 Mar; 119(3):335-44. PubMed ID: 20111867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Model systems of protein-misfolding diseases reveal chaperone modifiers of proteotoxicity.
    Brehme M; Voisine C
    Dis Model Mech; 2016 Aug; 9(8):823-38. PubMed ID: 27491084
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [A Therapeutic Target for Inhibition of Neurodegeneration: Autophagy].
    Pupyshev AB; Korolenko TA; Tikhonova MA
    Zh Vyssh Nerv Deiat Im I P Pavlova; 2016 Sep; 66(5):515-540. PubMed ID: 30695399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Amyloid Oligomers: A Joint Experimental/Computational Perspective on Alzheimer's Disease, Parkinson's Disease, Type II Diabetes, and Amyotrophic Lateral Sclerosis.
    Nguyen PH; Ramamoorthy A; Sahoo BR; Zheng J; Faller P; Straub JE; Dominguez L; Shea JE; Dokholyan NV; De Simone A; Ma B; Nussinov R; Najafi S; Ngo ST; Loquet A; Chiricotto M; Ganguly P; McCarty J; Li MS; Hall C; Wang Y; Miller Y; Melchionna S; Habenstein B; Timr S; Chen J; Hnath B; Strodel B; Kayed R; Lesné S; Wei G; Sterpone F; Doig AJ; Derreumaux P
    Chem Rev; 2021 Feb; 121(4):2545-2647. PubMed ID: 33543942
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.